ROHAN PALEKAR
CIK 1423327 · Chief Executive Officer · last filed 2026-02-24
ROHAN PALEKAR is a Chief Executive Officer who has filed 60 SEC Form 4 insider transactions across 5 companies since 2008. The most recent filing, for NGNE, was dated Feb 24, 2026. Across all open-market trades the lifetime net is −$4.0M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
5
60
-$3.95M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NGNE | Director | — | $29.10 | — | $0 | 4 | 2026-02-24 |
| 89bio, Inc. (ETNB) Delisted | Chief Executive Officer | 0 | $14.84 | $0 | -$1.43M | 31 | 2025-10-30 |
| Neurogene Inc. (NLTX) Delisted | Director | — | $13.96 | — | $0 | 3 | 2023-06-09 |
| AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | SVP & Chief Commercial Officer | 302,806 | — | — | -$418.0K | 10 | 2014-11-28 |
| MEDIVATION, INC. (MDVN) Delisted | Chief Commercial Officer | 16,666 | — | — | -$2.10M | 12 | 2011-04-21 |
Recent Filings
60 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-24 | NGNE | Grant (A) | — | $0 | EDGAR |
| 2025-10-30 | 89bio, Inc. (ETNB) Delisted | Mixed | −809,273 | $0 | EDGAR |
| 2025-08-05 | 89bio, Inc. (ETNB) Delisted | Tax (F) | −55,836 | -$511.5K | EDGAR |
| 2025-06-13 | NGNE | Grant (A) | — | $0 | EDGAR |
| 2025-02-19 | 89bio, Inc. (ETNB) Delisted | Tax (F) | −3,249 | -$34.3K | EDGAR |
| 2025-02-11 | 89bio, Inc. (ETNB) Delisted | Tax (F) | −8,946 | -$102.1K | EDGAR |
| 2025-02-04 | 89bio, Inc. (ETNB) Delisted | Mixed | +402,402 | -$92.1K | EDGAR |
| 2024-12-10 | 89bio, Inc. (ETNB) Delisted | Buy (P) | +5,000 | $39.5K | EDGAR |
| 2024-11-25 | 89bio, Inc. (ETNB) Delisted | Buy (P) | +10,000 | $83.5K | EDGAR |
| 2024-08-19 | 89bio, Inc. (ETNB) Delisted | Tax (F) | −4,601 | -$37.0K | EDGAR |